Specials
 Search
 Contact Us
 Create an account
 Customer Login
  Shopping
  Cart
now in your cart 12 items
    
browse by categories
    Audio Conference Archive
    Audio Conferences
    Past Conference Documentation
    Webinar Archive
    Webinars
    Workshops
product
Evolution of Patient Registries: Parexel
This product was added to our catalog on Thursday 23 April, 2009.
Item #:
Price:  $395.00
  
Product description
90 Minute Webinar Video

Speaker
Nayan Nanavati, Vice President Peri-Approval Clinical Excellence, Americas
Clinical Research Services
Evolution of Patient Registries: Parexel PAREXEL International


Patient registries differ from traditional clinical research and data collection in their unique capability to capture and manage reported outcomes over an extended period of time. Within the last several years, there has been substantial growth in the use of patient registries. The role and contribution of registries to the clinical development of drugs and to support a successful market introduction is continuing to evolve. A growing regulatory environment for these studies creates a situation in which patient registries provide great opportunity, but also creates challenges. This webinar explored the optimal use, regulatory boundaries, and the future of various patient registries, including those for orphan drugs, devices, restricted access, and pregnancy.
  • Optimal use of patient registries
  • Challenges
  • Opportunities
  • Regulatory framework
  • Future of patient registries

About the Speaker

Nayan Nanavati serves as Vice President, Peri Approval Clinical Excellence (PACE™), Americas in the Clinical Research Services business of PAREXEL International, a leading global biopharmaceutical services provider.

Mr. Nanavati oversees a global team, which provides biopharmaceutical companies with a broad range of capabilities to support their product launch and marketing plans. He has in-depth expertise in late phase clinical development, including patient registries, safety studies, outcomes research, pharmacovigilance, pharmacoepidemiology, and expanded access programs. Mr. Nanavati is focused on providing clients with customized strategic and scientific solutions to move products from development to commercialization in a seamless and cost-effective manner.

With more than 20 years of experience in the clinical product development industry and having worked extensively in peri- and post-approval clinical research, Mr. Nanavati has overseen several approvals and global launches for various products, across a broad range of therapeutic areas.


Cost
The cost to purchase the video recording is $395.

Once your order is processed you will shipped a copy of the video file on flash drive. The video comes in windows media format and can easily be played on your computer.
  Copyright 2010 Q1 Productions